ensodata research

Treating Sleep Apnea Resulted in 20% Lower Medical Spend in 2 Million Patient OSA Actuarial Study

EnsoData analyzed the impact of Untreated Obstructive Sleep Apnea (OSA) on Chronic Comorbid Conditions and Healthcare Costs in this OSA Actuarial Study.

Part Two: EnsoData’s Final SLEEP 2021 Abstracts

Dive into the last two abstracts published by the EnsoData team at SLEEP 2021.

EnsoData’s Sleep 2021 Abstracts – Part 1

Dive into the brief overviews of our poster-worthy research.